FIELD: pharmacology.
SUBSTANCE: compounds of 8-fluorophthalazine-1(2H)-ones of formula II
are proposed, wherein one of X1, X2 and X3 represent N, and the other symbols have meanings defined in claim 1 of the invention formula, or stereoisomers, gautomers and pharmaceutically acceptable salts thereof. The compounds proposed inhibit the kinase Btk (Bruton tyrosine kinase) and can be used to treat immune disorders, such as inflammation, mediated by kinase Btk.
EFFECT: increased efficiency while using the compounds of formula II for the diagnosis and treatment in vitro, in situ and in vivo such disorders in mammalian cells, or associated pathological conditions.
25 cl, 8 dwg, 2 tbl, 69 ex
Title | Year | Author | Number |
---|---|---|---|
BRUTON'S TYROSINE KINASE INHIBITORS | 2010 |
|
RU2542585C2 |
PYRIDONE AND AZA-PYRIDONE COMPOUNDS AND METHODS OF USE | 2011 |
|
RU2617405C2 |
NOVEL PYRIDOPYRIMIDINONE COMPOUNDS FOR MODULATION OF CATALYTIC ACTIVITY OF HISTONE LYSINE DEMETHYLASES (KDMS) | 2015 |
|
RU2684396C2 |
AMINOTRIAZOLOPYRIDINES AND USING THEM AS KINASE INHIBITORS | 2009 |
|
RU2552642C2 |
BRUTON'S TYROSINE KINASE INHIBITORS | 2014 |
|
RU2618529C2 |
HETEROYRYL PYRIDONES AND AZAPIRIDONS WITH ELECTROPHILIC FUNCTIONALITY | 2014 |
|
RU2646758C2 |
SPIRO AMINO COMPOUNDS APPLICABLE FOR TREATING SLEEP DISORDERS AND DRUG ADDICTION | 2010 |
|
RU2562609C2 |
DIHYDROPYRIDOPHTHALAZINONE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE | 2009 |
|
RU2514937C2 |
INHIBITOR CONTAINING BICYCLIC DERIVATIVE, METHOD OF PREPARATION AND USE THEREOF | 2020 |
|
RU2820948C2 |
PYRIDOPYRIMIDINONE DERIVATIVES AND USE THEREOF AS AROMATIC HYDROCARBON RECEPTOR MODULATORS | 2021 |
|
RU2818954C1 |
Authors
Dates
2017-06-15—Published
2012-11-02—Filed